Uppsala, Sweden

Ib Mendel-Hartvig

This inventor holds 21 USPTO granted patents and 3 published patent applications, plus 8 CIPO patents and 11 EPO patents, primarily in Assay Devices. Top assignees: Johnson & Johnson Gmbh, Amic Ab, Pharmacia Diagnostics Ab. Active years: 2004-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ib Mendel-Hartvig. Retrieved from https://idiyas.com/inventor/ib-mendel-hartvig

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 85.7


 

Average Co-Inventor Count = 2.6

ph-index = 9

Forward Citations = 273(Granted Patents)


Company Filing History:


Years Active: 2004-2017

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Assay Device
Fluorescence Reader
Micro Fluidic Structures
Coagulation Monitoring
Capillary Transport
Analytical Method
Fluid Transport
Optical Assay System
Test Kit
Circulating Antibodies
Timer Function
Serial Reaction Zones
21 patents (USPTO):Explore Patents

Title: Ib Mendel-Hartvig: Innovator in Assay Technology

Introduction

Ib Mendel-Hartvig is a prominent inventor based in Uppsala, Sweden, known for his contributions to assay devices and methods. With a total of 21 patents to his name, Mendel-Hartvig has established himself as a crucial figure in the field of biomedical innovations, particularly in coagulation monitoring technologies.

Latest Patents

Among his latest inventions are two noteworthy patents:

1. **Assay Device and Method** - This invention features an assay device that includes a lid and a base. The base is designed with a sample addition zone, a reaction zone, and an absorbing zone that are interconnected, forming a fluid passage. Key components include an integrated sample addition well in the lid and an absorbing zone on a non-porous substrate with perpendicular projections that define the sample volume for the assay. Additionally, the device includes a filter positioned between the sample addition well and the sample addition zone, advancing the methodology for efficient sample handling.

2. **Lateral Flow Assay Device for Coagulation Monitoring and Method Thereof** - This innovative device aims to improve the monitoring and measurement of coagulation. It features a non-porous substrate designed to receive a liquid sample and incorporates a defined flow path zone. This zone includes a clotting agent, which accelerates coagulation and promotes the formation of a uniformly distributed clot, resulting in a measurable change in flow rate or cessation of flow along the device.

Career Highlights

Throughout his career, Ib Mendel-Hartvig has collaborated with renowned companies such as Johnson & Johnson and Amic AB, contributing his expertise to innovative projects that push the boundaries of assay technology. His extensive patent portfolio reflects his commitment to advancing medical diagnostics.

Collaborations

In his journey, Mendel-Hartvig has worked alongside talented individuals including Per Ove Öhman and Tomas Lindstrom. These collaborations have enriched his work, bringing diverse perspectives and expertise to the development of his inventions.

Conclusion

Ib Mendel-Hartvig's contributions to the field of assay devices underscore his impact as an inventor. With a portfolio of 21 patents, his work continues to lead advancements in the monitoring of coagulation, reflecting a dedication to innovation and improvement in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…